
NICE updates managing COVID guideline with new monoclonal antibody recommendations
NICE has updated its managing COVID-19 guideline to include new recommendations on using monoclonal antibodies to treat COVID-19 patients in hospital.
All NICE products on antimicrobial stewardship. Includes any guidance, advice and quality standards.
We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
Published advice on this topic (19)
Set out priority areas for quality improvement in health and social care.
Published quality standards on this topic (3)
Review the evidence across broad health and social care topics.
Review new diagnostic technologies for adoption in the NHS.
Review the best available evidence for selected medicines.
Review the evidence and likely costs of medical devices and technologies.
Guidance, quality standards and advice being developed.
NICE has updated its managing COVID-19 guideline to include new recommendations on using monoclonal antibodies to treat COVID-19 patients in hospital.
NICE has updated its advice on two therapeutics for managing COVID-19 – remdesivir and colchicine.
One year on from the first national lockdown, NICE has today (23 March) published a single guideline for the management of COVID-19 in children and adults.
Rosie explains how new NICE guidance will help us all in the fight against antibiotic resistance
Di has been working hard to teach her students about the importance of hand-washing. Find out how she has got on.
Examples of how our guidance and standards have been put into practice in the NHS, local authorities, voluntary sector and a range of other organisations.
Showing 3 of 20 shared learning examples for this topic: